ARTICLE SUMMARY:
This once un-fundable project may very well be medtech’s hottest start-up as it heads toward a cure/treatment for metastatic cancers.
All successful fund-raising represents an affirmation of sorts. But for Hayward, CA-based RefleXion Medical, the company’s recent announcement of a $52 million Series B, led by a sophisticated family-office (KCK) and with the participation of Johnson & Johnson Development Corporation (JJDC), represented a special kind of affirmation.
